Compliance Program - Community Health Plan of Washington - Medicare Advantage

Compliance Program

Compliance Program Policies and Procedures

Our Compliance Department is committed to ensuring member information is secure and that both employees and providers comply with all federal and state regulations plan practices. If you are new provider with us, we recommend that you review all of these policies as part of your on-boarding process.

Standards of Conduct

Community Health Plan of Washington’s Standards of Conduct
Community Health Plan of Washington’s Standards of Conduct (Spanish)

Compliance Today Newsletter

Read updates from the Compliance department and stay up to date on the latest policy changes and initiatives.

Volume Q2 2020
Volume Q4 2019
Volume Q3 2019
Volume Q2 2019
Volume Q1 2019
Volume Q4 2018
Volume Q3 2018
Volume Q2 2018
Volume Q1 2018
Volume Q4 2017
Volume Q3 2017
Volume Q2 2017
Volume Q1 2017


DRUG RECALL: Ranitidine Hydrochloride (HCL) 150mg and 300 mg

Group of doctors and nurses looking to and discussing x-ray image at clinic.

On September 23, 2019, SANDOZ recalled Ranitidine HCL due to the presence of an impurity. The U.S. Food and Drug Administration (FDA) has issued a Class II recall of the affected medications.

Recalled Drug: Ranitidine 150mg and Ranitidine 300mg
NDC Number: 00781285560, 00781286531
Lot Numbers:
HD8625, HD9275, HU2207, HX6676, HX6677, HC9266, HD1865, HP9441, JK7994, JK8659, HD1862, HP9438, HP9439, HP9440



Sales Team

Get real answers
from real people

Phone: 1-800-944-1247